NDC Package 14403-3400-2 Liraglutide
Injection, Solution Subcutaneous - View Billable Units, 11-Digit Format, RxNorm
Package Information
Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.
- RxCUI: 897122 - liraglutide 6 MG/ML in 3 ML Pen Injector
- RxCUI: 897122 - 3 ML liraglutide 6 MG/ML Pen Injector
- RxCUI: 897122 - liraglutide 18 MG per 3 ML Pen Injector
- Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
- Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
- Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
- GLP-1 Receptor Agonist - [EPC] (Established Pharmacologic Class)
- Glucagon-Like Peptide 1 - [CS]
- Glucagon-like Peptide-1 (GLP-1) Agonists - [MoA] (Mechanism of Action)
- GLP-1 Receptor Agonist - [EPC] (Established Pharmacologic Class)
- Glucagon-Like Peptide 1 - [CS]
- Glucagon-like Peptide-1 (GLP-1) Agonists - [MoA] (Mechanism of Action)
- GLP-1 Receptor Agonist - [EPC] (Established Pharmacologic Class)
- Glucagon-Like Peptide 1 - [CS]
- Glucagon-like Peptide-1 (GLP-1) Agonists - [MoA] (Mechanism of Action)
- 14403 - Hybio Pharmaceutical Co., Ltd. (pingshan Factory)
- 14403-3400 - Liraglutide
- 14403-3400-2 - 2 SYRINGE, PLASTIC in 1 CARTON / 3 mL in 1 SYRINGE, PLASTIC (14403-3400-1)
- 14403-3400 - Liraglutide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the disclaimer below.
Other Product Packages
The following packages are also available for this product:
NDC Package Code | Package Description |
---|---|
14403-3400-1 | 3 mL in 1 SYRINGE, PLASTIC |
14403-3400-3 | 3 SYRINGE, PLASTIC in 1 CARTON / 3 mL in 1 SYRINGE, PLASTIC (14403-3400-1) |
* Please review the disclaimer below.
Frequently Asked Questions
What is NDC 14403-3400-2?
The NDC Packaged Code 14403-3400-2 is assigned to a package of 2 syringe, plastic in 1 carton / 3 ml in 1 syringe, plastic (14403-3400-1) of Liraglutide, a human prescription drug labeled by Hybio Pharmaceutical Co., Ltd. (pingshan Factory). The product's dosage form is injection, solution and is administered via subcutaneous form.
Is NDC 14403-3400 included in the NDC Directory?
Yes, Liraglutide with product code 14403-3400 is active and included in the NDC Directory. The product was first marketed by Hybio Pharmaceutical Co., Ltd. (pingshan Factory) on June 21, 2024 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.
What is the 11-digit format for NDC 14403-3400-2?
The 11-digit format is 14403340002. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.
This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:
10-Digit Format | 10-Digit Original Code | 11-Digit Format | 11-Digit Code |
---|---|---|---|
5-4-1 | 14403-3400-2 | 5-4-2 | 14403-3400-02 |